Serwis Infona wykorzystuje pliki cookies (ciasteczka). Są to wartości tekstowe, zapamiętywane przez przeglądarkę na urządzeniu użytkownika. Nasz serwis ma dostęp do tych wartości oraz wykorzystuje je do zapamiętania danych dotyczących użytkownika, takich jak np. ustawienia (typu widok ekranu, wybór języka interfejsu), zapamiętanie zalogowania. Korzystanie z serwisu Infona oznacza zgodę na zapis informacji i ich wykorzystanie dla celów korzytania z serwisu. Więcej informacji można znaleźć w Polityce prywatności oraz Regulaminie serwisu. Zamknięcie tego okienka potwierdza zapoznanie się z informacją o plikach cookies, akceptację polityki prywatności i regulaminu oraz sposobu wykorzystywania plików cookies w serwisie. Możesz zmienić ustawienia obsługi cookies w swojej przeglądarce.
BACKGROUND
In the first CONCORD study (2008), 5‐year survival for patients diagnosed with colon cancer between 1990 and 1994 in the United States was among the highest in the world (60%), but there were large racial disparities in most participating states. The CONCORD‐2 study (2015) enabled the examination of survival trends between 1995 and 2009 for US states by race and stage.
METHODS
The authors...
BACKGROUND
Results from the second CONCORD study (CONCORD‐2) indicated that 5‐year net survival for lung cancer was low (range, 10%‐20%) between 1995 and 2009 in most countries, including the United States, which was at the higher end of this range.
METHODS
Data from CONCORD‐2 were used to analyze net survival among patients with lung cancer (aged 15‐99 years) who were diagnosed in 37 states covering...
CONCORD is a programme for the global surveillance of cancer survival. In 2015, the second cycle of the program (CONCORD‐2) established long‐term surveillance of cancer survival worldwide, for the first time, in the largest cancer survival study published to date. CONCORD‐2 provided cancer survival trends for 25,676,887 patients diagnosed during the 15‐year period between 1995 and 2009 with 1 of 10...
BACKGROUND
The 5‐year relative survival for prostate cancers diagnosed between 1990 and 1994 in the United States was very high (92%); however, survival in black males was 7% lower compared with white males. The authors updated these findings and examined survival by stage and race.
METHODS
The authors used data from the CONCORD‐2 study for males (ages 15‐99 years) who were diagnosed with prostate...
BACKGROUND
Robust comparisons of population‐based cancer survival estimates require tight adherence to the study protocol, standardized quality control, appropriate life tables of background mortality, and centralized analysis. The CONCORD program established worldwide surveillance of population‐based cancer survival in 2015, analyzing individual data on 26 million patients (including 10 million...
BACKGROUND
Ovarian cancer is the fifth leading cause of cancer death among women in the United States. This study reports ovarian cancer survival by state, race, and stage at diagnosis using data from the CONCORD‐2 study, the largest and most geographically comprehensive, population‐based survival study to date.
METHODS
Data from women diagnosed with ovarian cancer between 2001 and 2009 from 37...
BACKGROUND
Stomach cancer was a leading cause of cancer‐related deaths early in the 20th century and has steadily declined over the last century in the United States. Although incidence and death rates are now low, stomach cancer remains an important cause of morbidity and mortality in black, Asian and Pacific Islander, and American Indian/Alaska Native populations.
METHODS
Data from the CONCORD‐2...
BACKGROUND
Overall, cervical cancer survival in the United States has been reported to be among the highest in the world, despite slight decreases over the last decade. Objective of the current study was to describe cervical cancer survival trends among US women and examine differences by race and stage.
METHODS
This study used data from the CONCORD‐2 study to compare survival among women (aged...
BACKGROUND
Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy. This report describes the survival of children with ALL in the United States using the most comprehensive and up‐to‐date cancer registry data.
METHODS
Data from 37 state cancer registries that cover approximately 80% of the US population were used. Age‐standardized survival up to 5 years was estimated for children...
BACKGROUND
Worldwide, liver cancer is a leading cause of death for both men and women. The number of Americans who are diagnosed with and die of liver cancer has been rising slowly each year. Using data from the CONCORD‐2 study, this study examined population‐based survival by state, race, and stage at diagnosis.
METHODS
Data from 37 statewide registries, which covered 81% of the US population,...
BACKGROUND
In the first CONCORD study, 5‐year survival for patients with diagnosed with rectal cancer between 1990 and 1994 was <60%, with large racial disparities noted in the majority of participating states. We have updated these findings to 2009 by examining population‐based survival by stage of disease at the time of diagnosis, race, and calendar period.
METHODS
Data from the CONCORD‐2...
Because cancer registry data provide a census of cancer cases, registry data can be used to: 1) define and monitor cancer incidence at the local, state, and national levels; 2) investigate patterns of cancer treatment; and 3) evaluate the effectiveness of public health efforts to prevent cancer cases and improve cancer survival. The purpose of this article is to provide a broad overview of the history...
BACKGROUND
Reducing breast cancer incidence and achieving equity in breast cancer outcomes remains a priority for public health practitioners, health care providers, policy makers, and health advocates. Monitoring breast cancer survival can help evaluate the effectiveness of health services, quantify inequities in outcomes between states or population subgroups, and inform efforts to improve the...
Podaj zakres dat dla filtrowania wyświetlonych wyników. Możesz podać datę początkową, końcową lub obie daty. Daty możesz wpisać ręcznie lub wybrać za pomocą kalendarza.